Article Details
Retrieved on: 2025-06-07 12:28:23
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Aytu BioPharma (AYTU) secures exclusive rights to commercialize EXXUAâ„¢ (gepirone) in the U.S. for Major Depressive Disorder (MDD).
Article found on: www.gurufocus.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here